| Spiroindolones, a potent compound class for the treatment of malaria M Rottmann, C McNamara, BKS Yeung, MCS Lee, B Zou, B Russell, ... science 329 (5996), 1175-1180, 2010 | 1196 | 2010 |
| PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release R Singh, U Manjunatha, HIM Boshoff, YH Ha, P Niyomrattanakit, ... Science 322 (5906), 1392-1395, 2008 | 921 | 2008 |
| Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus P Erbel, N Schiering, A D'Arcy, M Renatus, M Kroemer, SP Lim, Z Yin, ... Nature structural & molecular biology 13 (4), 372-373, 2006 | 634 | 2006 |
| Spirotetrahydro β-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria BKS Yeung, B Zou, M Rottmann, SB Lakshminarayana, SH Ang, ... Journal of medicinal chemistry 53 (14), 5155-5164, 2010 | 456 | 2010 |
| An adenosine nucleoside inhibitor of dengue virus Z Yin, YL Chen, W Schul, QY Wang, F Gu, J Duraiswamy, RR Kondreddi, ... Proceedings of the National Academy of Sciences 106 (48), 20435-20439, 2009 | 393 | 2009 |
| A practical view of ‘druggability’ TH Keller, A Pichota, Z Yin Current opinion in chemical biology 10 (4), 357-361, 2006 | 339 | 2006 |
| Wnt addiction of genetically defined cancers reversed by PORCN inhibition B Madan, Z Ke, N Harmston, SY Ho, AO Frois, J Alam, DA Jeyaraj, ... Oncogene 35 (17), 2197-2207, 2016 | 322 | 2016 |
| A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy K Pethe, PC Sequeira, S Agarwalla, K Rhee, K Kuhen, WY Phong, V Patel, ... Nature communications 1 (1), 57, 2010 | 316 | 2010 |
| A small-molecule dengue virus entry inhibitor QY Wang, SJ Patel, E Vangrevelinghe, HY Xu, R Rao, D Jaber, W Schul, ... Antimicrobial agents and chemotherapy 53 (5), 1823-1831, 2009 | 239 | 2009 |
| Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead Z Yin, SJ Patel, WL Wang, G Wang, WL Chan, KRR Rao, J Alam, ... Bioorganic & medicinal chemistry letters 16 (1), 36-39, 2006 | 212 | 2006 |
| Small molecule inhibitors that selectively block dengue virus methyltransferase SP Lim, LS Sonntag, C Noble, SH Nilar, RH Ng, G Zou, P Monaghan, ... Journal of Biological Chemistry 286 (8), 6233-6240, 2011 | 185 | 2011 |
| Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors Z Yin, SJ Patel, WL Wang, WL Chan, KRR Rao, G Wang, X Ngew, V Patel, ... Bioorganic & medicinal chemistry letters 16 (1), 40-43, 2006 | 181 | 2006 |
| Structure− activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4-and 5-nitroimidazoles P Kim, L Zhang, UH Manjunatha, R Singh, S Patel, J Jiricek, TH Keller, ... Journal of medicinal chemistry 52 (5), 1317-1328, 2009 | 124 | 2009 |
| Inhibition of dengue virus polymerase by blocking of the RNA tunnel P Niyomrattanakit, YL Chen, H Dong, Z Yin, M Qing, JF Glickman, K Lin, ... Journal of virology 84 (11), 5678-5686, 2010 | 123 | 2010 |
| Imidazolopiperazines: hit to lead optimization of new antimalarial agents T Wu, A Nagle, K Kuhen, K Gagaring, R Borboa, C Francek, Z Chen, ... Journal of medicinal chemistry 54 (14), 5116-5130, 2011 | 116 | 2011 |
| A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease C Bodenreider, D Beer, TH Keller, S Sonntag, D Wen, LJ Yap, YH Yau, ... Analytical biochemistry 395 (2), 195-204, 2009 | 116 | 2009 |
| Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis M Kurabachew, SHJ Lu, P Krastel, EK Schmitt, BL Suresh, A Goh, ... Journal of antimicrobial chemotherapy 62 (4), 713-719, 2008 | 115 | 2008 |
| Structural dynamics of Zika virus NS2B-NS3 protease binding to dipeptide inhibitors Y Li, Z Zhang, WW Phoo, YR Loh, W Wang, S Liu, MW Chen, AW Hung, ... Structure 25 (8), 1242-1250. e3, 2017 | 110 | 2017 |
| The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist F Baur, D Beattie, D Beer, D Bentley, M Bradley, I Bruce, SJ Charlton, ... Journal of medicinal chemistry 53 (9), 3675-3684, 2010 | 110 | 2010 |
| Global Bayesian models for the prioritization of antitubercular agents P Prathipati, NL Ma, TH Keller Journal of chemical information and modeling 48 (12), 2362-2370, 2008 | 110 | 2008 |
Jeffrey HillInstitute of Chemical Biology, Shenzhen Bay LaboratoriesVerified email at szbl.ac.cn
